WALTHAM, Mass., March 12, 2015 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., today announced that Arlene Morris, president and chief executive officer, will be participating in two upcoming conferences.
- 22nd Annual Future Leaders in the Biotech Industry Conference: Arlene Morris will be presenting a corporate overview on Friday, March 20, 2015 at 3:30 p.m. EDT at the Millennium Broadway Hotel & Conference Center in New York City.
- BIO Asia International Conference: Arlene Morris will be participating in a panel titled “Emerging Deal-Making Trends in Japan” on Wednesday, March 25, 2015 at 9:00 a.m. JST at the Grand Hyatt Tokyo.
About Syndax
Syndax is developing entinostat, an oral, highly selective HDAC inhibitor with epigenetic and immunomodulatory activity that is being evaluated in multiple combination regimens for the treatment of patients with therapy-resistant cancers. Entinostat has been designated a Breakthrough Therapy by the FDA when used in combination with exemestane in HR+ advanced (locally advanced or metastatic) breast cancer. A pivotal Phase 3 clinical study, being conducted under a special protocol assessment (SPA), combining entinostat with exemestane for the treatment of hormone receptor-positive metastatic breast cancer is currently enrolling. Syndax is also developing an immuno-oncology platform to improve responsiveness to checkpoint inhibitors based on entinostat’s ability to down-regulate immune suppressor cells. Syndax holds rights to entinostat in most major markets.
Syndax Contacts
Corporate:
Bob Goodenow
Chief Business Officer
Syndax Pharmaceuticals
(781) 419-1418
bgoodenow@syndax.com
Investor:
Robert Flamm, Ph.D.
Russo Partners
(212) 845-4226
robert.flamm@russopartnersllc.com
Media:
David Schull or Matt Middleman, M.D.
Russo Partners
(212) 845-4271
(212) 845-4272
david.schull@russopartnersllc.com
matt.middleman@russopartnersllc.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/syndax-to-participate-in-two-upcoming-conferences-300046734.html
SOURCE Syndax Pharmaceuticals, Inc.
Help employers find you! Check out all the jobs and post your resume.
